LGND
LIGAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$314.77
+0.40%Leverage
- Debt / equity
- 1.20x
- Net debt / equity
- 1.14x
- Debt / assets
- 0.52x
- Debt / EBITDA
- 14.33x
- Net debt / EBITDA
- 13.64x
Liquidity & coverage
- Current ratio
- 1.22x
- Quick ratio
- 1.19x
- Cash ratio
- 0.89x
- Interest coverage
- 5.73x
- EBITDA / interest
- 15.25x
- Working capital
- $107.7M
Cash & dividend
- FCF / debt
- 0.08x
- Cash flow / debt
- 0.08x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -95.1%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026